
    
      This study aims at allowing a better understanding of which circulating tumor cells (CTC)
      have the higher risk of metastasis of in the overall population of CTC.

      Prospective monocenter open-label study.

      In the frame of the management of the disease, blood samples will be collected at different
      times of treatment, regarding disease status (localized of stage II/III, metastatic non
      resectable, metastatic potentially resectable). Tissue samples will be collected for patients
      scheduled for surgery.
    
  